KalshiCheck availabilityKYC requiredVerified resolution dataWell calibratedData quality warningStale data
Data as of Oct 26, 2026, 10:51 AM UTC · policy pm-quality-4
Selected book midpoint
Above 8k · —
Loading selected book…
—
Stored price
Above 28k 68.5%Market line of 15 lines
Above 28k 68.5%Market quality
30 / 100
Low quality24h Volume
—
Open interest
$15.5K
Medium open interestBid / Ask
— / —
Above 8kSpread
—
Market data
Updated 2 hours ago
StaleJul 14, 26, 7:30 PM UTCJan 1, 27, 2:59 PM UTC
Chart and changes show stored historical probabilities, not the selected live book.
Trends
Selected row: book midpoint. Other rows: stored references, possibly normalized; 24h changes use stored history.
Venue terms
Source: Kalshi
Informational venue terms only; CoinRithm paper trading uses its own rules.
- Early close:
- Yes
- Settlement timer:
- 30m (informational)
Market depth · Above 8k
Loading selected book…
—
Related Markets
Related questions for context, not a comparison of equivalent contracts.
Total cases of measles reported in US during 2026
Manifold MarketsHow many tuberculosis cases will be reported in the United States in 2026?
KalshiHow many West Nile neuroinvasive disease cases will be reported among New York City residents in 2026?
PolymarketHow many mpox clade Ib cases will be reported in the United States in 2026?
KalshiHow many locally acquired dengue cases will be reported in Florida in 2026?
KalshiHow many human H5N1 cases will be reported in the United States in 2026?
KalshiRules
If the total number of Cyclosporiasis cases reported in the United States during 2026 is above 28000, then the market resolves to Yes.
- Cases are determined at 10:00 AM ET on the Expiration Date (January 8). Cases that actually occur between the end of the specified time period and Expiration do not count, but newly reported cases during this window do count if they are backdated to 2026. See the full rules for how Source Agencies are prioritized.
Rules for each outcome
- Above 8k
- If the total number of Cyclosporiasis cases reported in the United States during 2026 is above 8000, then the market resolves to Yes.
- Above 12k
- If the total number of Cyclosporiasis cases reported in the United States during 2026 is above 12000, then the market resolves to Yes.
- Above 14k
- If the total number of Cyclosporiasis cases reported in the United States during 2026 is above 14000, then the market resolves to Yes.
- Above 4k
- If the total number of Cyclosporiasis cases reported in the United States during 2026 is above 4000, then the market resolves to Yes.
- Above 10k
- If the total number of Cyclosporiasis cases reported in the United States during 2026 is above 10000, then the market resolves to Yes.
- Above 16k
- If the total number of Cyclosporiasis cases reported in the United States during 2026 is above 16000, then the market resolves to Yes.
- Above 6k
- If the total number of Cyclosporiasis cases reported in the United States during 2026 is above 6000, then the market resolves to Yes.
- Above 18k
- If the total number of Cyclosporiasis cases reported in the United States during 2026 is above 18000, then the market resolves to Yes.
- Above 20k
- If the total number of Cyclosporiasis cases reported in the United States during 2026 is above 20000, then the market resolves to Yes.
- Above 22k
- If the total number of Cyclosporiasis cases reported in the United States during 2026 is above 22000, then the market resolves to Yes.
- Above 24k
- If the total number of Cyclosporiasis cases reported in the United States during 2026 is above 24000, then the market resolves to Yes.
- Above 26k
- If the total number of Cyclosporiasis cases reported in the United States during 2026 is above 26000, then the market resolves to Yes.
- Above 30k
- If the total number of Cyclosporiasis cases reported in the United States during 2026 is above 30000, then the market resolves to Yes.
- Above 28k
- If the total number of Cyclosporiasis cases reported in the United States during 2026 is above 28000, then the market resolves to Yes.
- Above 32k
- If the total number of Cyclosporiasis cases reported in the United States during 2026 is above 32000, then the market resolves to Yes.